Literature DB >> 11472408

Complete arrest from pro- to pre-B cells in a case of B cell-negative severe combined immunodeficiency (SCID) without recombinase activating gene (RAG) mutations.

K Agematsu1, H Nagumo, S Hokibara, T Mori, T Wada, A Yachie, H Kanegane, T Miyawaki, K Sugita, H Karasuyama, A Komiyama.   

Abstract

The B-cell lineage in a patient with B-cell-negative severe combined immunodeficiency (SCID) was analysed by using antisurrogate light chain (SL) MoAbs. Peripheral CD3(+) T cells and CD19(+) B cells were absent in the patient. The common gamma (gamma c) chain was expressed normally on the patient's peripheral NK cells and his peripheral mononuclear cells did not possess any mutations in recombinase activating gene (RAG)-1, 2. Normal levels of expression of Ku70 and Ku80 protein were found by Western blot analysis. The patient did, however, display an increase in fibroblast sensitivity to irradiation. Furthermore, flow cytometric analyses of bone marrow cells showed that surface IgM and cytoplasmic mu positive cells were absent and that CD19(+) B cells were composed of only CD34(+) terminal deoxynucleotidyl transferase (TdT)(+) SL(+) pro-B cells. The complete arrest of pro- to pre-B cell development in the SCID patient's bone marrow suggests that some genes involved in V(D)J recombination, excepting the RAG gene, may play a causative role in the immunodeficiency.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11472408      PMCID: PMC1906068          DOI: 10.1046/j.1365-2249.2001.01553.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  The human (PsiL+mu-) proB complex: cell surface expression and biochemical structure of a putative transducing receptor.

Authors:  B Lemmers; L Gauthier; V Guelpa-Fonlupt; M Fougereau; C Schiff
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

Review 2.  Clonal selection and learning in the antibody system.

Authors:  K Rajewsky
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

3.  Mutations in the mu heavy-chain gene in patients with agammaglobulinemia.

Authors:  L Yel; Y Minegishi; E Coustan-Smith; R H Buckley; H Trübel; L M Pachman; G R Kitchingman; D Campana; J Rohrer; M E Conley
Journal:  N Engl J Med       Date:  1996-11-14       Impact factor: 91.245

4.  Increased radiosensitivity of granulocyte macrophage colony-forming units and skin fibroblasts in human autosomal recessive severe combined immunodeficiency.

Authors:  M Cavazzana-Calvo; F Le Deist; G De Saint Basile; D Papadopoulo; J P De Villartay; A Fischer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  The expression of Vpre-B/lambda 5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice.

Authors:  H Karasuyama; A Rolink; Y Shinkai; F Young; F W Alt; F Melchers
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

6.  Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood.

Authors:  N Ishii; T Takeshita; Y Kimura; K Tada; M Kondo; M Nakamura; K Sugamura
Journal:  Int Immunol       Date:  1994-08       Impact factor: 4.823

Review 7.  The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling.

Authors:  W J Leonard
Journal:  Annu Rev Med       Date:  1996       Impact factor: 13.739

8.  Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants.

Authors:  R H Buckley; R I Schiff; S E Schiff; M L Markert; L W Williams; T O Harville; J L Roberts; J M Puck
Journal:  J Pediatr       Date:  1997-03       Impact factor: 4.406

9.  Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway.

Authors:  K Nomura; H Kanegane; H Karasuyama; S Tsukada; K Agematsu; G Murakami; S Sakazume; M Sako; R Tanaka; Y Kuniya; T Komeno; S Ishihara; K Hayashi; T Kishimoto; T Miyawaki
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

10.  RAG mutations in human B cell-negative SCID.

Authors:  K Schwarz; G H Gauss; L Ludwig; U Pannicke; Z Li; D Lindner; W Friedrich; R A Seger; T E Hansen-Hagge; S Desiderio; M R Lieber; C R Bartram
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

View more
  1 in total

1.  RAG1 deficiency may present clinically as selective IgA deficiency.

Authors:  Tamaki Kato; Elena Crestani; Chikako Kamae; Kenichi Honma; Tomoko Yokosuka; Takeshi Ikegawa; Naonori Nishida; Hirokazu Kanegane; Taizo Wada; Akihiro Yachie; Osamu Ohara; Tomohiro Morio; Luigi D Notarangelo; Kohsuke Imai; Shigeaki Nonoyama
Journal:  J Clin Immunol       Date:  2015-03-06       Impact factor: 8.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.